Literature DB >> 2981070

Secreted mouse prolactin (PRL) and stored ovine PRL. II. Role of amides in receptor binding and immunoreactivity.

L S Haro, F J Talamantes.   

Abstract

Native PRL and des-amido forms 1, 2, and 3 were tested for their individual immunochemical and receptor-binding abilities. The results show that deamidation of either secreted mouse PRL or stored ovine PRL alters their binding in a radioreceptor assay. For each accumulated deamidation there was a statistically significant (P less than 0.05) decrease in the binding potency of either stored ovine PRL or secreted mouse PRL to a cell membrane receptor preparation. RIAs indicated that there was a statistically significant (P less than 0.05) decrease in PRL's immunopotency toward polyclonal antisera only when select residues deamidated. This study suggests that all the asn/gln residues which deamidate in order to make des-amido forms 1, 2, and 3 constitute part of the receptor-binding domains of both secreted and stored PRLs, while only a fraction of those same residues form portions of PRL's antigenic sites. Thus PRL's receptor-binding surface is separated from its antigenic sites, with only partial overlap being indicated. Our data also indicate that there are no major structural differences in the receptor-binding domains of secreted and stored PRLs. We also see that the receptor-binding domain of PRL has been highly conserved throughout evolution. Since the binding affinity of PRL to a membrane-bound receptor can be altered through deamidation, we view the process as a plausible regulatory mechanism for controlling the quantitative action of PRL at a given target organ.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981070     DOI: 10.1210/endo-116-1-353

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

Review 1.  Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

Authors:  KuangTzu Huang; Eric Ueda; YenHao Chen; Ameae M Walker
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

2.  Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities.

Authors:  Juan J Bustamante; Alexei L Grigorian; Jesus Muñoz; Roberto M Aguilar; Lisa R Treviño; Andrew O Martinez; Luis S Haro
Journal:  Growth Horm IGF Res       Date:  2010-05-15       Impact factor: 2.372

3.  Bioactivity and immunoreactivity of rat pituitary prolactin submitted to various extraction procedures.

Authors:  M I Prada; H A Pasolli; A I Torres; A Aoki
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

4.  Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation.

Authors:  K D F Vlugt-Wensink; R de Vrueh; M G Gresnigt; C M Hoogerbrugge; S C van Buul-Offers; L G J de Leede; L G W Sterkman; D J A Crommelin; W E Hennink; R Verrijk
Journal:  Pharm Res       Date:  2007-10-11       Impact factor: 4.200

5.  Isolation and characterization of phosphorylated bovine prolactin.

Authors:  B G Kim; C L Brooks
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.